Polypharmacology by design: a medicinal chemist's perspective on multitargeting compounds
… , crystallography, or fragment-based design equip multitarget compound development
with valuable tools. In this Perspective, we analyze the relevance of multiple ligands in drug …
with valuable tools. In this Perspective, we analyze the relevance of multiple ligands in drug …
Rational multitargeted drug design strategy from the perspective of a medicinal chemist
X Li, X Li, F Liu, S Li, D Shi - Journal of Medicinal Chemistry, 2021 - ACS Publications
The development of multitarget-directed ligands (MTDLs) has become a widely focused
research topic, but rational design remains as an enormous challenge. This paper reviews and …
research topic, but rational design remains as an enormous challenge. This paper reviews and …
Multi-target drugs: Strategies and challenges for medicinal chemists
R Morphy, Z Rankovic - The Practice of Medicinal Chemistry, 2008 - Elsevier
… different approaches to multitarget therapy. … compounds produced by medicinal chemists
were screened by in vivo pharmacologists in whole animal models of disease. This approach …
were screened by in vivo pharmacologists in whole animal models of disease. This approach …
[HTML][HTML] Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective
A Talevi - Frontiers in pharmacology, 2015 - frontiersin.org
… While medicinal chemists usually rely on some version of the lock and key paradigm to … to
compounds with unfavorable biopharmaceutic or pharmacokinetic profile (eg, compounds that …
compounds with unfavorable biopharmaceutic or pharmacokinetic profile (eg, compounds that …
[HTML][HTML] A perspective on multi-target drug discovery and design for complex diseases
… approach and related chemoinformatic methods application are described in comprehensive
overview about the development of tacrine- and donepezil-like multitarget compounds for …
overview about the development of tacrine- and donepezil-like multitarget compounds for …
[HTML][HTML] One drug for multiple targets: A computational perspective
O Méndez-Lucio, JJ Naveja, H Vite-Caritino… - Journal of the Mexican …, 2016 - scielo.org.mx
… target-specific drugs are discussed including the rationale, the ‘master key compound’
concept and safety panels to address the possible unwanted effects of drugs multi-targeting. The …
concept and safety panels to address the possible unwanted effects of drugs multi-targeting. The …
Hybrid compounds as direct multitarget ligands: a review
M Oliveira Pedrosa, RM Duarte da Cruz… - … topics in medicinal …, 2017 - ingentaconnect.com
… updated review of molecular hybridization and multitarget profiling (a rational drug design
approach), and its applications to the design and discovery of novel hybrid compounds with …
approach), and its applications to the design and discovery of novel hybrid compounds with …
The multitarget approach as a green tool in medicinal chemistry
… This allows for identification of synergistic effects of multiple small molecules and ligands
to design a single multitarget compound from them. All these techniques still have a long way …
to design a single multitarget compound from them. All these techniques still have a long way …
Rational design of multitarget-directed ligands: strategies and emerging paradigms
J Zhou, X Jiang, S He, H Jiang, F Feng… - Journal of medicinal …, 2019 - ACS Publications
… Compound 3 was reported as a new multitarget therapeutic candidate, which incorporated
the … This work identified a novel approach to design multitarget drugs with pharmacophores …
the … This work identified a novel approach to design multitarget drugs with pharmacophores …
Designing multiple ligands-medicinal chemistry strategies and challenges
R Morphy, Z Rankovic - Current pharmaceutical design, 2009 - ingentaconnect.com
… A major advantage of the screening approach is that it provides a compound that already …
the fact that starting compounds obtained via screening already possess multitarget activity, so …
the fact that starting compounds obtained via screening already possess multitarget activity, so …